Related Experiment Videos
Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice
Research Communications in Chemical Pathology and Pharmacology
|November 1, 1976
Summary
Morphine withdrawal jumping in mice involves dopamine changes. Dopaminergic drugs like apomorphine can reduce this behavior, suggesting dopamine plays a role in inhibiting withdrawal symptoms.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Opioid withdrawal, specifically abrupt withdrawal jumping behavior in morphine-dependent mice, is a significant research area.
- Previous studies suggest a link between dopamine system alterations and opioid withdrawal symptoms.
Purpose of the Study:
- To investigate the role of dopamine in morphine withdrawal jumping behavior.
- To determine the effects of dopaminergic agents on naloxone-precipitated and abrupt withdrawal jumping.
Main Methods:
- Assessing brain dopamine turnover and levels during morphine withdrawal in mice.
- Administering the dopaminergic agonist apomorphine and antagonist haloperidol to observe their effects on jumping behavior.
- Examining strain differences in jumping incidence.
Main Results:
- Abrupt withdrawal jumping correlated with decreased dopamine turnover and increased dopamine levels.
- Apomorphine dose-dependently inhibited both naloxone-precipitated and abrupt withdrawal jumping.
- Haloperidol blocked apomorphine's inhibitory effect but did not block naloxone-precipitated jumping.
Conclusions:
- Findings suggest a decrease in dopamine release during withdrawal jumping behavior.
- Dopaminergic activation appears to be inhibitory to morphine withdrawal jumping.
- The dopamine system is implicated in the neurobiology of opioid withdrawal.